Hirsutism, postpartum telogen effluvium, and male pattern alopecia

Journal of Cosmetic Dermatology

Volumn 5, Issue 1, 2006, Pages 81-86

  Millikan, Larry ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hirsutism; Postpartum androgenetic alopecia; Postpartum telogen effluvium

Indexed keywords

ANDROGEN RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIANDROGEN; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ATORVASTATIN; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CLINDAMYCIN; CYCLOSPORIN; DIANE; DIURETIC AGENT; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GINSENG EXTRACT; GLUCOCORTICOID RECEPTOR; GREEN TEA EXTRACT; GRISEOFULVIN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOTRETINOIN; LOPINAVIR; MACROLIDE; METFORMIN; PROGESTERONE RECEPTOR; RITONAVIR; SPIRONOLACTONE; UNINDEXED DRUG; YASMINE;

ABDOMINAL CRAMP; ACNE; AMENORRHEA; BLOATING; BREAST DISEASE; CHLOASMA; CHOLESTASIS; DISEASE EXACERBATION; EDEMA; ESTROGEN METABOLISM; FOOD DRUG INTERACTION; HAIR GROWTH; HEART INFARCTION; HIRSUTISM; HORMONE ACTION; HUMAN; HYPERTENSION; LIVER ADENOMA; MALE TYPE ALOPECIA; MATERNAL DISEASE; MENSTRUATION DISORDER; NAUSEA; PATHOGENESIS; POSTPARTUM TELOGEN EFFLUVIUM; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; THROMBOEMBOLISM; VOMITING;

ALOPECIA; FEMALE; HAIR; HIRSUTISM; HORMONES; HUMANS; MALE; PREGNANCY; PUERPERAL DISORDERS;

EID: 33645548580     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2006.00229.x     Document Type: Review

References (13)

1. Graham-Brown RAC. The ages of man and their dermatoses. In Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology Vol. 4, 6th edn. Oxford: BlaPkwell. 1998: pp. 3259-69.
2. Vaughan-Jones SA, Black MM. Pregnancy-related conditions. In: Parish LC, Brenner S, Rames-e-Silva M, eds. London: Parthenon; Women's Dermatology - from Infancy to Maturity 2001: Pp. 397-413.
3. Dawber R, Van Neste D. Hair and Scalp Disorders: Common Presenting Signs, Differential Diagnosis and Treatment. London: Martin Dunitz; 1995: Pp. 16-23.
4. Schuhmacher-Stock U. Estrogen treatment of hair diseases. In: CE Orfanos, W Montagna, G Stuttgen, eds. Hair Research. Berlin: Springer Verlag; 1981: Pp. 318-21.
5. Franziska C, Paús R. Estrogens and the hair follicle. J German Soc Dermatol 2004: 412-23.
6. Paús R, Cotasrelis G. The biology of hair follicles. N Engl J Med 1999; 341 (7): 491-7.
7. Sinclair R. Hair structure and function. In: R Sinclair, C Banfiel, R Dawber, eds. Handbook of Diseases of the Hair and Scalp. New York: Blackwell, Oxford Press; 1999: 15-25.
8. Bulun SE, Zeitoun K, Sasano H, Simpson Er. Aromatase in aging women. Semin Reprod Endocrinol 1999; 17 (4): 349-58.
9. Thornton MJ. The biological actions of estrogens on skin. Exp Dermatol 2002; 11 (6): 487-502.
10. Burke BM, Cunliffe WJ. Oral spironolactone therapy for patients with acne, hirsutism or androgenetic alopecia. Br J Dermatol 1985; 112 (1): 124-5.
11. Kaufman KD, Olsen EA, Whiting DA et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998; 39: 578-89.
12. Thai KE, Sinclair RD. Finasteride for female androgenetic alopecia. Br J Dermatol 2002; 147: 812-3.
13. Vexiau P, Chaspoux C, Boudou P et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: A controlled 12-month randomized trial. Br J Dermatol 2002; 146: 992-9.